Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | GSE161676 | SRA Run Selector | |||||||
GSM5643581 |
chemo baseline scRNAseq tech rep 2
|
SRA | 1 |
|
Mark Dawson | Nov 08, 2021 | |||
GSM5643582 |
chemo disease endpoint scRNA-seq pool 1
|
SRA | 1 |
|
Mark Dawson | Nov 08, 2021 | |||
GSM5643583 |
chemo disease endpoint scRNA-seq pool 2
|
SRA | 1 |
|
Mark Dawson | Nov 08, 2021 | |||
GSM5643584 |
chemo disease endpoint scRNA-seq pool 1 hashtag library
|
SRA | 1 |
|
Mark Dawson | Nov 08, 2021 | |||
GSM5643585 |
chemo disease endpoint scRNA-seq pool 2 hashtag library
|
SRA | 1 |
|
Mark Dawson | Nov 08, 2021 | |||
GSM5643586 |
retransplant baseline scRNAseq mouse 6 bone marrow
|
SRA | 1 |
|
Mark Dawson | Nov 08, 2021 | |||
GSM5643587 |
retransplant baseline scRNAseq mouse 6 spleen
|
SRA | 1 |
|
Mark Dawson | Nov 08, 2021 | |||
GSM5643588 |
wild type C57BL/6 #1
|
SRA | 1 |
|
|
Mark Dawson | Nov 08, 2021 | ||
GSM5643589 |
wild type C57BL/6 #2
|
SRA | 1 |
|
|
Mark Dawson | Nov 08, 2021 | ||
GSM5643590 |
tertiary MLL-AF9 #1
|
SRA | 1 |
|
|
Mark Dawson | Nov 08, 2021 | ||
GSM5643591 |
tertiary MLL-AF9 #2
|
SRA | 1 |
|
|
Mark Dawson | Nov 08, 2021 |